Abstracts - faqs.org

Abstracts

Retail industry

Search abstracts:
Abstracts » Retail industry

Agency backs drug-test kits

Article Abstract:

Fears expressed by UK Drugs Co-ordinator, Keith Hellawell, over two drug detection kits met with a response from the drug and legal body, Release, on 27 May 1998. A private firm is offering the Easy Test at GB 5 while the Green Party is offering another devise at GB 15 or GB 34. The kits can identify six different drugs, including MDMA and ecstasy, and can detect pills which have been mixed with other substances like speed. Release believes that young people should be able to use the kits, which are designed to combat the sometimes fatal affect of rogue drugs. However, Mr Hellawell believes that the kits should be banned and were immoral because they offer people a false sense of security.

Comment:

UK: Drugs Coordinator expresses fears by over 2 drug detection kits met w/ a response from drug & legal body on 5/27/98

Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 1998
Product information, Other Diagnostic Analyzers & Tests, Article

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A doctor in the house? No, but there's a home-test kit...

Article Abstract:

There are now many different home-test kits available in the UK. These can identify conditions such as diabetes before clear symptoms appear. Some observers believe that the use of home-test kits should be encouraged, as early diagnosis can in some cases prevent a condition becoming fatal. However, others have reservations about the reliability of some tests. In particular, there is concern about the possibility of tests giving a false negative result, incorrectly indicating that the individual is healthy.

Author: Baker, Peter
Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 1998
Diagnostic Test Kits & Reagents, Usage, Medical tests

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


UK: NO FEE FOR BREAST CANCER TEST

Article Abstract:

Rosgen, the British licensee of all patents for breast cancer tests has agreed to waive royalties on National Health Service tests based on the sequences of two genes involved in tumour formation. Not charging royalties means that more tests can be carried out, thus preventing the denial of treatment to patients who genuinely need medical help.

Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
Financial management, Cancer Test Kits, Finance, Brief Article, Medical examination, Medical equipment industry, Breast examination, Medical test kit industry, Cancer diagnosis, Rosgen

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United Kingdom, Medical testing products
Similar abstracts:
  • Abstracts: A battle to satisfy out passion for the stars. At last the children are heard. Abusers' charter goes unchecked
  • Abstracts: An industry in crisis? Not quite. Bertolucci's model composer. The tale of two Traviatas
  • Abstracts: Is she or isn't she? Is there anybody out there with Di?
  • Abstracts: An epidemic - or just a big wheeze? A well connected hostage is first to be freed. Life's no joke in the lawyers' chamber of horrors
  • Abstracts: A battleground to be. Just a single orange in the fridge: the facts of life in a 'food desert.' My dad the hero
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.